Matteo Lambertini: First ESMOYOC session at ESMO Asia 2024
Matteo Lambertini shared a post on X:
“Full house for the first ESMOYOC session at ESMO Asia24. ”
ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region.
ESMO Asia 2024 features scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer.
Its educational sessions provides in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.
Matteo Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital and the University of Genova in Italy. He specializes in managing breast cancer in young women, particularly addressing fertility and pregnancy-related issues post-diagnosis. Lambertini’s notable research includes using GnRH agonists during chemotherapy to preserve ovarian function and studying the safety of pregnancy after breast cancer. He also serves on the scientific boards of ESMO, ESHRE, and AIOM for fertility preservation in cancer patients.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023